lisdexamfetamine dimesylate
Generic: lisdexamfetamine
Labeler: amneal pharmaceuticals llcDrug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine
Labeler
amneal pharmaceuticals llc
Dosage Form
CAPSULE
Routes
Active Ingredients
lisdexamfetamine dimesylate 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65162-024
Product ID
65162-024_5fde01e6-09ba-4a92-bd47-aad0d7c518e4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202830
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2023-08-28
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65162024
Hyphenated Format
65162-024
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine (source: ndc)
Application Number
ANDA202830 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1
Packaging
- 90 CAPSULE in 1 BOTTLE (65162-024-09)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5fde01e6-09ba-4a92-bd47-aad0d7c518e4", "openfda": {"upc": ["0365162023091", "0365162027099", "0365162025095", "0365162024098", "0365162028096", "0365162026092"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850"], "spl_set_id": ["c11cb3b6-3dff-477b-a249-b4c3118edc5f"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (65162-024-09)", "package_ndc": "65162-024-09", "marketing_start_date": "20230828"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "65162-024_5fde01e6-09ba-4a92-bd47-aad0d7c518e4", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "65162-024", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "30 mg/1"}], "application_number": "ANDA202830", "marketing_category": "ANDA", "marketing_start_date": "20230828", "listing_expiration_date": "20261231"}